Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm Tagraxofusp (Elzonris; SL-401) Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Haematological Cancer and Lymphomas 2018 View  |  Download
Talazoparib in addition to enzalutamide for metastatic castration-resistant prostate cancer Enzalutamide (Xtandi; MDV3100) , Talazoparib (MDV3800; BMN-673; Talzenna; talazoparib tosylate) Prostate cancer Male Reproductive Cancer 2021 View  |  Download
Talazoparib with enzalutamide for previously untreated homologous recombination repair-mutated metastatic hormonal-sensitive prostate cancer Enzalutamide (Xtandi; MDV3100) , Talazoparib (MDV3800; BMN-673; Talzenna; talazoparib tosylate) Prostate cancer Male Reproductive Cancer 2024 View  |  Download
Talimogene laherparepvec in addition to pembrolizumab for metastatic melanoma Pembrolizumab (Keytruda; MK-3475) , Talimogene laherparepvec (Imlygic; T-Vec) Melanoma Skin Cancer 2020 View  |  Download
Talquetamab for previously treated relapsed or refractory multiple myeloma Talquetamab Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Tanezumab for cancer pain due to bone metastasis Tanezumab (PF-04383119; RN624) Cancer pain Bone and Cartilage Cancer , Oncology 2020 View  |  Download
Tanezumab for moderate to severe chronic pain associated with osteoarthritis and chronic low back pain Tanezumab (PF-04383119; RN624) Back pain , Osteoarthritic pain Musculoskeletal System , Pain Relief , Rheumatology 2019 View  |  Download
Tarlatamab for relapsed/refractory small-cell lung cancer Tarlatamab Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2023 View  |  Download
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride) Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Taselisib in Combination with Fulvestrant for Advanced ER Positive, HER2-negative Breast Cancer – Second Line After Aromatase Inhibitor Therapy Fulvestrant (Faslodex) , Taselisib (GDC-0032; RG-7604) Breast cancer Breast Cancer 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications